392 related articles for article (PubMed ID: 10664659)
1. [Immunology. Realizable discoveries].
Kabelitz D
Dtsch Med Wochenschr; 1999 Dec; 124(51-52):1570-2. PubMed ID: 10664659
[No Abstract] [Full Text] [Related]
2. [Immunology--risk management in the body].
Kabelitz D
Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1563-5. PubMed ID: 15965863
[No Abstract] [Full Text] [Related]
3. [The impact of immunology on modern medicine].
Caetano M
Acta Med Port; 1983; 4(7-8):373-6. PubMed ID: 6356798
[No Abstract] [Full Text] [Related]
4. Cancer immunotherapy with autologous and allogeneic vaccines: a practical overview.
Shinitzky M; Skornick Y
Prog Clin Biol Res; 1990; 348():95-125. PubMed ID: 2201036
[No Abstract] [Full Text] [Related]
5. Immunology in Malaysia--a review.
Bosco J
Ann Acad Med Singap; 1988 Apr; 17(2):251-3. PubMed ID: 3044263
[TBL] [Abstract][Full Text] [Related]
6. [Importance of progress achieved in fundamental biomedical sciences, especially in immunology, for the design of new vaccines].
Louis J
Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1208-9. PubMed ID: 8766631
[TBL] [Abstract][Full Text] [Related]
7. The optimal technological approach to the development of human hybridomas.
Dorfman NA
J Biol Response Mod; 1985 Jun; 4(3):213-39. PubMed ID: 2991473
[No Abstract] [Full Text] [Related]
8. The HLA system. Second of two parts.
Klein J; Sato A
N Engl J Med; 2000 Sep; 343(11):782-6. PubMed ID: 10984567
[No Abstract] [Full Text] [Related]
9. Cancer immunology--an overview.
Richards V
Prog Exp Tumor Res; 1980; 25():1-60. PubMed ID: 6986628
[No Abstract] [Full Text] [Related]
10. Improving Vaccine and Immunotherapy Design Using Biomaterials.
Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
[TBL] [Abstract][Full Text] [Related]
11. [Immunology today].
Günther O
Allerg Immunol (Leipz); 1971; 17(2):167-82. PubMed ID: 4261245
[No Abstract] [Full Text] [Related]
12. [Tumor immunology].
Cerni CM
Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
[No Abstract] [Full Text] [Related]
13. Host responses to malignant disease.
Cochran AJ
Br J Dermatol; 1970 Jul; 83(1):208-12. PubMed ID: 4393811
[No Abstract] [Full Text] [Related]
14. Tolerogenic dendritic cells in cancer, transplantation, and autoimmune diseases.
Suciu-Foca N; Berloco P; Cortesini R
Hum Immunol; 2009 May; 70(5):277-80. PubMed ID: 19275919
[No Abstract] [Full Text] [Related]
15. [Immunological novelties for clinicians].
Meri S; Jalanko H; Hurme M
Duodecim; 1994; 110(2):175-7. PubMed ID: 7555789
[No Abstract] [Full Text] [Related]
16. Clinical immunology. Report of a WHO scientific group.
Int Arch Allergy Appl Immunol; 1972; 42(5):Suppl:1-50. PubMed ID: 4268950
[No Abstract] [Full Text] [Related]
17. Cross-talk between innate and adaptive immune responses in infection, transplant and autoimmune models.
Wasowska BA
Curr Opin Organ Transplant; 2011 Feb; 16(1):1-6. PubMed ID: 21654356
[No Abstract] [Full Text] [Related]
18. International reviews of immunology: expanding the scope and content.
Bot A; Smith K
Int Rev Immunol; 2008; 27(4):177-82. PubMed ID: 18574735
[No Abstract] [Full Text] [Related]
19. Current Opinion in Immunology. Vaccines. Introduction.
Ertl HC; Lanzavecchia A
Curr Opin Immunol; 2010 Jun; 22(3):355-7. PubMed ID: 20510596
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function.
Vlad G; Chang CC; Colovai AI; Berloco P; Cortesini R; Suciu-Foca N
Hum Immunol; 2009 May; 70(5):340-4. PubMed ID: 19275918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
